Author： Denis Alain
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.29, Iss.10, 2011-10, pp. : 883-893
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
An Orphan Disorder in Need of New Drugs
Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 5, 2004-10 ,pp. :
Access to resources
Recommend
A Proposal to Improve the Supply of Orphan Drugs
By Minghetti P.M. Giudici E.M. Montanari L.
Pharmacological Research, Vol. 42, Iss. 1, 2000-07 ,pp. :
Spending on orphan drugs: European perspective
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 614, 2010-01 ,pp. :
Six new drugs on Finland's special reimbursement list
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 273, 2000-01 ,pp. :
Savings gained from reimbursement restrictions on nebulised drugs
Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. :